{"id":"NCT01885208","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes","officialTitle":"Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes (SUSTAIN™ 3 - vs. QW GLP-1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12-02","primaryCompletion":"2015-07-13","completion":"2015-07-13","firstPosted":"2013-06-24","resultsPosted":"2018-03-30","lastUpdate":"2019-06-13"},"enrollment":813,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"semaglutide","otherNames":[]},{"type":"DRUG","name":"exenatide","otherNames":["Bydureon®"]}],"arms":[{"label":"Semaglutide 1.0 mg","type":"EXPERIMENTAL"},{"label":"Exenatide ER 2.0 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of semaglutide once-weekly versus exenatide ER (extended release) 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (Glycosylated Haemoglobin)","timeFrame":"Week 0, week 56","effectByArm":[{"arm":"Semaglutide 1.0 mg","deltaMin":-1.54,"sd":0.06},{"arm":"Exenatide ER 2.0 mg","deltaMin":-0.92,"sd":0.06}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":146,"countries":["United States","Argentina","Croatia","Finland","France","Germany","Greece","Italy","Netherlands","Puerto Rico","Serbia","Switzerland","United Kingdom"]},"refs":{"pmids":["30938762","30865526","29246950","29687620","29748996","29766634","29862621","29907893","30535837","30615985","30047216","36056351","32998732","32827435","32193837","31903692","31769496","31215727"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":404},"commonTop":["Nausea","Lipase increased","Diarrhoea","Headache","Nasopharyngitis"]}}